165 related articles for article (PubMed ID: 4401857)
1. Resistance to beta-adrenoceptor stimulatnts.
Feinmann L
Br Med J; 1972 Apr; 2(5807):229-30. PubMed ID: 4401857
[No Abstract] [Full Text] [Related]
2. Pharmacology and logic.
Falliers CJ
J Allergy; 1969 Jul; 44(1):59. PubMed ID: 5254401
[No Abstract] [Full Text] [Related]
3. beta-Adrenergic bronchodilators and sudden death in asthmatics.
Drug Ther Bull; 1976 Mar; 14(6):21-2. PubMed ID: 6237
[No Abstract] [Full Text] [Related]
4. [Overdosed aerosols and mortality of bronchial asthma].
Beritić T; Vurdelja B
Lijec Vjesn; 1969 Aug; 91(8):900-3. PubMed ID: 4910068
[No Abstract] [Full Text] [Related]
5. Efficacy of a new bronchodilator, soterenol, on experimental locked-lung syndrome in dogs.
Cho YW; Aviado DM; Lish PM
J Allergy; 1968 Jul; 42(1):36-48. PubMed ID: 5243797
[No Abstract] [Full Text] [Related]
6. [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].
Riedl-Seifert R
Dtsch Med Wochenschr; 2007 Mar; 132(12):633; author reply 633-4. PubMed ID: 17357910
[No Abstract] [Full Text] [Related]
7. [Study of the bronchodilator effect of a new sympathomimetic preparation in measured aerosols].
Charpin J; Grimaud C; Ohresser P; Boutin C; Aubert J; Casanova P
Mars Med; 1967; 104(6):585-8. PubMed ID: 5618406
[No Abstract] [Full Text] [Related]
8. The adverse effect of adrenergic aerosols in bronchial asthma.
Eisenstadt WS; Nicholas SS
Ann Allergy; 1969 Jun; 27(6):283-8. PubMed ID: 5785920
[No Abstract] [Full Text] [Related]
9. Albuterol and isoproterenol aerosols. A controlled study of duration of effect in asthmatic patients.
Snider GL; Laguarda R
JAMA; 1972 Aug; 221(7):682-5. PubMed ID: 5068267
[No Abstract] [Full Text] [Related]
10. Resistance to beta-adrenoceptor stimulants and death from bronchial asthma.
Blackwell EW; Conolly ME; Davies DS; Dollery CT; George CF
Br J Pharmacol; 1971 Feb; 41(2):410P. PubMed ID: 4396706
[No Abstract] [Full Text] [Related]
11. Epidemiologic studies of beta agonists and asthma deaths.
Pearce N; Hensley MJ
Epidemiol Rev; 1998; 20(2):173-86. PubMed ID: 9919437
[No Abstract] [Full Text] [Related]
12. [Adrenergic broncholytic agents. Different causes and symptoms of adverse effects].
Vale JR
Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2442-3. PubMed ID: 4144336
[No Abstract] [Full Text] [Related]
13. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].
Virchow C
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240
[No Abstract] [Full Text] [Related]
14. [beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League].
Gillissen A; Berdel D; Buhl R; Crieé CP; Kardos P; Magnussen H; Rabe KF; Rolke M; Vogelmeier C; Worth H; Virchow JC
Dtsch Med Wochenschr; 2007 Jan; 132(1-2):33-9. PubMed ID: 17187322
[No Abstract] [Full Text] [Related]
15. [Update on beta-adrenergic agonists and corticosteroid aerosols].
Spector S
Rev Alerg Mex; 1993; 40(6):i-iv. PubMed ID: 9296815
[No Abstract] [Full Text] [Related]
16. Beta-agonist therapy and asthma mortality in Japan.
Beasley R; Nishima S; Pearce N; Crane J
Lancet; 1998 May; 351(9113):1406-7. PubMed ID: 9593418
[No Abstract] [Full Text] [Related]
17. Blood-levels of fluorinated hydrocarbons in asthmatic patients after inhalation of pressurised aerosols.
Paterson JW; Sudlow MF; Walker SR
Lancet; 1971 Sep; 2(7724):565-8. PubMed ID: 4106103
[No Abstract] [Full Text] [Related]
18. Beta adrenergic stimulant aerosols in bronchial asthma: an assessment.
Srivastava BN; Shrivastava VK; Rao VS; Vyas GP; Kochar AS
Indian J Chest Dis; 1973 Apr; 15(2):123-31. PubMed ID: 4580542
[No Abstract] [Full Text] [Related]
19. Clinical pharmacology of adrenergic drugs.
Popa VT
J Asthma; 1984; 21(3):183-207. PubMed ID: 6145698
[No Abstract] [Full Text] [Related]
20. Adrenergic drugs.
Bierman CW
Clin Rev Allergy; 1983 Mar; 1(1):87-104. PubMed ID: 6142760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
